Your browser doesn't support javascript.
loading
Medidas farmacológicas para la prevención de la neumonía asociada a la ventilación mecánica / Pharmacologic measures for the prevention of mechanical ventilation-associated pneumonia
Ulldemolins, Marta; Restrepo, Marcos I; Rello, Jordi.
Affiliation
  • Ulldemolins, Marta; Hospital Universitario de Tarragona Joan XXIII. Servicio de medicina Intensiva. Tarragona. España
  • Restrepo, Marcos I; Hospital Universitario de Tarragona Joan XXIII. Servicio de medicina Intensiva. Tarragona. España
  • Rello, Jordi; Hospital Universitario de Tarragona Joan XXIII. Servicio de medicina Intensiva. Tarragona. España
Med. clín (Ed. impr.) ; 136(1): 21-25, ene. 2011. tab
Article in Spanish | IBECS | ID: ibc-85359
Responsible library: ES1.1
Localization: BNCS
RESUMEN
La neumonía asociada a la ventilación mecánica (NAV) es la complicación infecciosa que representa la mayor causa de morbimortalidad en las unidades de cuidados intensivos. Debido a su complicado diagnóstico y tratamiento, la prevención de la NAV es una tarea prioritaria. La interrupción diaria de la sedación, la descontaminación oral y digestiva, el uso profiláctico de antibióticos sistémicos o inhalados, el control de la glucemia, la profilaxis de la úlcera de estrés, el protocolo de transfusión y el tiempo y la adecuación del tratamiento antimicrobiano son las principales intervenciones clásicamente indicadas.Esta revisión de la bibliografía discute críticamente las principales medidas farmacológicas para la prevención de la NAV y focaliza en su nivel de evidencia y en la idoneidad de aplicarlas en la práctica clínica habitual (AU)
ABSTRACT
Ventilator associated pneumonia is the principal infectious complication in the Intensive Care Unit (ICU), and represents the main infectious cause of morbidity and mortality. Its diagnosis and management is complex. Consequently, its prevention becomes a cornerstone in daily clinical practice. Daily interruption of sedation, oral and digestive decontamination, prophylactic administration of systemic and/or inhaled antibiotics, glycemic control, stress ulcer prophylaxis, transfusion policy and timing and adequacy of antibiotic treatment are the main suggested pharmacologic interventions.The aim of this review is to critically describe the principal pharmacologic interventions for the prevention of ventilator associated pneumonia, focusing on the degree of the evidence and the appropriateness for daily clinical practice (AU)
Subject(s)
Search on Google
Collection: National databases / Spain Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being / SDG3 - Target 3.3 End transmission of communicable diseases / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.4: Reduce premature mortality due to noncommunicable diseases / Pneumonia / Other Respiratory Diseases Database: IBECS Main subject: Pneumonia / Respiration, Artificial / Cross Infection Type of study: Practice guideline / Risk factors Limits: Humans Language: Spanish Journal: Med. clín (Ed. impr.) Year: 2011 Document type: Article Institution/Affiliation country: Hospital Universitario de Tarragona Joan XXIII/España
Search on Google
Collection: National databases / Spain Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being / SDG3 - Target 3.3 End transmission of communicable diseases / SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.4: Reduce premature mortality due to noncommunicable diseases / Pneumonia / Other Respiratory Diseases Database: IBECS Main subject: Pneumonia / Respiration, Artificial / Cross Infection Type of study: Practice guideline / Risk factors Limits: Humans Language: Spanish Journal: Med. clín (Ed. impr.) Year: 2011 Document type: Article Institution/Affiliation country: Hospital Universitario de Tarragona Joan XXIII/España
...